Neuroblu Database News Today

Rapid digitalization in the health industry is set to drive M&A across the region - Digitalization is reshaping the global healthcare industry as demand for personalized,...

Veradigm Inc. and Holmusk have announced the next step in their strategic collaboration helping them move closer to their vision of creating a single source of truth for behavioral health.

While CGI-S scores predicted hospitalization risk, trends associated with clinical instability and severity were similar but independent.

While CGI-S scores predicted hospitalization risk, trends associated with clinical instability and severity were similar but independent.

According to a new study published in The Lancet Psychiatry, illness severity and clinical instability are two critical factors for predicting future hospitalization risk among patients with psychiatric conditions. This finding could be integral for behavioral

/PRNewswire/ -- For patients with psychiatric conditions, illness severity and instability are key factors in predicting future risk of hospitalization,...

First study of its kind, based on real-world data from Holmusk's NeuroBlu Database, shows patients who score highest for severity and instability were 45% more likely to be hospitalized NEW

For patients with psychiatric conditions, illness severity and instability are key factors in predicting future risk of hospitalization, according to a new study by Holmusk, a leading behavioral health real-world evidence and data analytics company, that has been published in The Lancet Psychiatry.

Health tech startup Holmusk secured $45.7 million this week from investors in Series B financing.

Heritas Capital-backed Holmusk secured $21.5 million in Series A funding in 2020.